NCT03154645View on ClinicalTrials.gov

Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 12, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

October 1, 2017

Conditions
Acute Mountain Sickness
Interventions
DRUG

Ibuprofen

non-steroidal anti-inflammatory drug

DRUG

Acetazolamide

a diuretic

Trial Locations (1)

93515

White Mountain Research Station, Bishop

All Listed Sponsors
lead

Grant S Lipman

OTHER

NCT03154645 - Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy | Biotech Hunter | Biotech Hunter